SELP and SELPLG genetic variation is associated with cell surface measures of SELP and SELPLG: The atherosclerosis risk in communities carotid MRI study

Clinical Chemistry

Volumn 55, Issue 6, 2009, Pages 1076-1082

  Volcik, Kelly A ^a,f   Catellier, Diane ^b   Folsom, Aaron R ^c   Matijevic, Nena ^d   Wasserman, Bruce ^e   Boerwinkle, Eric ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

^f UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN;

ADULT; AFRICAN AMERICAN; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL SURFACE; COHORT ANALYSIS; CORRELATION ANALYSIS; EUROPEAN AMERICAN; FEMALE; FLOW CYTOMETRY; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRANULOCYTE; HUMAN; INFLAMMATION; LEUKOCYTE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PROTEIN EXPRESSION; RISK FACTOR; SELP GENE; SELPLG GENE; THROMBOCYTE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; CAROTID ARTERIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FLOW CYTOMETRY; HUMANS; MAGNETIC RESONANCE IMAGING; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SELENOPROTEIN P;

EID: 66449084382     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.119487     Document Type: Article

References (37)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-126
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695
3. Elangbam CS, Qualls CW Jr, Dahlgren RR. Cell adhesion molecules - Update. Vet Pathol 1997;34:61-73. (Pubitemid 127473828)
4. Blann AD, Nadar SK, Lip GYH. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 2003;24:2166-2179 (Pubitemid 37522669)
5. Merten M, Thiagarajan P. P-selectin and arterial thrombosis. Z Kardiol 2004;93:855-863
6. Norman KE, Moore KL, McEver RP, Ley K. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. Blood 1995;86:4417-4421
7. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood 1996;88:3259-3287 (Pubitemid 26365560)
8. Tregouet DA, Barbaux S, Poirier O, Blankenberg S, Bickel C, Escolano S, et al. SELPLG gene polymorphisms in relation to plasma SELPLG levels and coronary artery disease. Ann Hum Genet 2003;67:504-511 (Pubitemid 38016711)
9. Johnson RC, Chapman SM, Dong ZM, Ordovas JM, Mayadas TN, Herz J, et al. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest 1997;99:1037-1043 (Pubitemid 27123641)
10. Nageh MF, Sandberg ET, Marotti KR, Lin AH, Melchior EP, Bullard DC, Beaudet AL. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1997;17:1517-1520 (Pubitemid 27387771)
11. Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 2000;101:2290-2295 (Pubitemid 30317132)
12. Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL. P-selectin or intercellular adhesion molecule (ICAM-1) deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 2000;191:189-194 (Pubitemid 30043660)
13. Molenaar TJM, Twisk J, de Haas SAM, Peterse N, Vogelaar BJCP, van Leeuwen SH, et al. P-selectin as a candidate target in atherosclerosis. Biochem Pharm 2003;66:859-866 (Pubitemid 37011424)
14. Koyama H, Maeno T, Fukumoto S, Shoji T, Yamane T, Yokoyama H, et al. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 2003;108:524-529 (Pubitemid 36961164)
15. Barbaux SC, Blankenberg S, Rupprecht HJ, Francomme C, Bickel C, Hafner G, et al. Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Arterioscler Thromb Vasc Biol 2001;21:1668-1673 (Pubitemid 34215589)
16. Carter AM, Anagnostopoulou K, Mansfield MW, Grant PJ. Soluble P-selectin levels, P-selectin polymorphisms and cardiovascular disease. J Thromb Haemost 2003;1:1718-1723
17. Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Wu KK, Boerwinkle E. P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the Atherosclerosis Risk in Communities Study. Atherosclerosis 2006;186:74-79
18. Miller MA, Kerry SM, Dong Y, Strazzullo P, Cappuccio FP. Association between the Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in a multiethnic population in South London. Thromb Haemost 2004;92:1060-1065 (Pubitemid 39545530)
19. Herrmann SM, Ricard S, Nicaud V, Mallet C, Evans A, Ruidavets JB, et al. The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet 1998;7:1277-1284 (Pubitemid 28383061)
20. Kee F, Morrison C, Evans AE, McCrum E, McMaster D, Dallongeville J, et al. Polymorphisms of the P-selectin gene and risk of myocardial infarction in men and women in the ECTIM extension study. Heart 2000;84:548-552
21. Tregouet DA, Barbaux S, Escolano S, Tahri N, Golmard JL, Tiret L, Cambien F. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 2002;11:2015-2023
22. Bugert P, Vosberg M, Entelmann M, Jahn J, Katus HA, Kluter H. Polymorphisms in the P-selectin (CD62P) and P-selectin glycoprotein ligand-1 (PSGL-1) genes and coronary heart disease. Clin Chem Lab Med 2004;42:997-1004. (Pubitemid 39307388)
23. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001;103:491-495
24. Lozano ML, Gonzalez-Conejero R, Corral J, Rivera J, Iniesta JA, Martinez C, Vicente V. Polymorphisms of P-selectin glycoprotein ligand-1 are associated with neutrophil-platelet adhesion and with ischaemic cerebrovascular disease. Brit J Haematol 2001;115:969-976 (Pubitemid 34042918)
25. Bugert P, Hoffmann MM, Winkelmann BR, Vosberg M, Jahn J, Entelmann M, et al. The variable number of tandem repeat polymorphism in the P-selectin glycoprotein ligand-1 gene is not associated with coronary heart disease. J Mol Med 2003;81:495-501. (Pubitemid 37070202)
26. Roldan V, Gonzalez-Conejero R, Marin F, Pineda J, Vicente V, Corral J. Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction. Am Heart J 2004; 148:602-605 (Pubitemid 39349378)
27. Fox JE. Shedding of adhesion receptors from the surface of activated platelets. Blood Coagul Fibrinolysis 1994;5:291-304. (Pubitemid 24138066)
28. Ishiwata N, Takio K, Katayama M, Watanabe K, Titani K, Ikeda Y, Hanada M. Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule. J Biol Chem 1994;269:23708-23715 (Pubitemid 24293578)
29. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989;129:687-702. (Pubitemid 19094247)
30. Catellier DJ, Aleksic N, Folsom AR, Boerwinkle E. Atherosclerosis Risk in Communities (ARIC) Carotid MRI. Flow cytometry study of monocyte and platelet markers: intraindividual variability and reliability. Clin Chem 2008;54:1363-1371
31. Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Boerwinkle E. Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2007;195:e76-82. (Pubitemid 47561962)
32. Moore KL, Patel KD, Bruehl RE, Li F, Johnson DA, Lichenstein HS, et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 1995;128:661-671
33. Vandendries ER, Furie BC, Furie B. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 2004;92:459-466 (Pubitemid 39248002)
34. Andre P, Hartwell D, Hrachovinová I, Saffaripour S, Wagner DD. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A 2000;97:13835-13840
35. Hartwell DW, Mayadas TN, Berger G, Frenette PS, Rayburn H, Hynes RO, Wagner DD. Role of P-selectin in granular targeting vivo and in early inflammatory responses. J Cell Biol 1998;143:1129-1141
36. Hrachovinová I, Cambien B, Hafezi-Moghadam A, Kappelmayer J, Camphausen RT, Widom A, et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 2003;9:1020-1025 (Pubitemid 37021781)
37. Snapp KR, Ding H, Atkins K, Warnke R, Luscinskas FW, Kansas GS. A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both Pand L-selectin. Blood 1998;91:154-164 (Pubitemid 28018740)